Vertex Pharmaceuticals Incorporated (0QZU.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 01:57PM GMT. Market open.
| Previous close | 300.65 |
| Open | 302.86 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 302.79 - 303.33 |
| 52-week range | 302.79 - 303.33 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 77.938B |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | 28.91 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's Why You Should Add CRISPR Stock to Your Portfolio
CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.
- Motley Fool
The Best Stocks to Invest $20,000 in Right Now
Critics of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) believe that the company is lagging behind OpenAI and Microsoft in the artificial intelligence (AI) race. It could be a huge mistake to underestimate Alphabet's AI expertise or Google Search's resilience.
- Zacks
Brokers Suggest Investing in Vertex (VRTX): Read This Before Placing a Bet
According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
© 2023 Yahoo. All rights reserved.
